10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Firebrick Pharma Ltd
Buy, Hold or Sell?

Let's analyze Firebrick Pharma Ltd together

I guess you are interested in Firebrick Pharma Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Firebrick Pharma Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Firebrick Pharma Ltd

I send you an email if I find something interesting about Firebrick Pharma Ltd.

1. Quick Overview

1.1. Quick analysis of Firebrick Pharma Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Firebrick Pharma Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.01
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-3.0%

For what price can you sell your share?

Current Price per Share
A$0.06
Expected price per share
A$0.055 - A$0.06
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Firebrick Pharma Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.06
Intrinsic Value Per Share
A$-0.02 - A$-0.01
Total Value Per Share
A$-0.01 - A$0.00

2.2. Growth of Firebrick Pharma Ltd (5 min.)




Is Firebrick Pharma Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.4m$2.5m-$1.3m-105.2%

How much money is Firebrick Pharma Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$271.5k-$1.7m$1.4m527.9%
Net Profit Margin-52.0%-97,796.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Firebrick Pharma Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Firebrick Pharma Ltd?

Welcome investor! Firebrick Pharma Ltd's management wants to use your money to grow the business. In return you get a share of Firebrick Pharma Ltd.

First you should know what it really means to hold a share of Firebrick Pharma Ltd. And how you can make/lose money.

Speculation

The Price per Share of Firebrick Pharma Ltd is A$0.057. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Firebrick Pharma Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Firebrick Pharma Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Firebrick Pharma Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-0.8%0.00-2.3%-0.01-9.5%0.00-5.7%0.00-5.7%
Usd Book Value Change Per Share0.000.0%0.00-0.5%0.00-8.1%0.000.8%0.000.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.00-0.5%0.00-8.1%0.000.8%0.000.8%
Usd Price Per Share0.04-0.03-0.15-0.08-0.08-
Price to Earnings Ratio-21.20--12.29--6.85--7.73--7.73-
Price-to-Total Gains Ratio3.83--17.46--0.70--0.70-
Price to Book Ratio5.56-6.00-12.86-6.62-6.62-
Price-to-Total Gains Ratio3.83--17.46--0.70--0.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0381045
Number of shares26243
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (26243 shares)-7.5312.62
Gains per Year (26243 shares)-30.1250.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-30-4005040
20-60-70010190
30-90-1000151140
40-120-1300202190
50-151-1600252240
60-181-1900303290
70-211-2200353340
80-241-2500404390
90-271-2800454440
100-301-3100505490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.014.00.00.0%0.014.00.00.0%0.014.00.00.0%
Book Value Change Per Share1.01.02.025.0%3.03.06.025.0%4.03.07.028.6%4.03.07.028.6%4.03.07.028.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share1.01.02.025.0%3.03.06.025.0%4.03.07.028.6%4.03.07.028.6%4.03.07.028.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Firebrick Pharma Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0000%-0.0070%0.001-100%0.001-100%
Book Value Per Share--0.0100.009+14%0.018-44%0.018-42%0.018-42%
Current Ratio--7.1886.177+16%7.808-8%9.761-26%9.761-26%
Debt To Asset Ratio--0.1210.152-20%0.129-6%0.114+6%0.114+6%
Debt To Equity Ratio--0.1380.181-24%0.151-9%0.132+4%0.132+4%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.002+193%-0.008+1126%-0.005+642%-0.005+642%
Free Cash Flow Per Share---0.003-0.003+7%-0.010+226%-0.007+117%-0.007+117%
Free Cash Flow To Equity Per Share---0.001-0.002+114%-0.009+648%-0.001-24%-0.001-24%
Gross Profit Margin--1.5171.306+16%1.041+46%1.132+34%1.132+34%
Intrinsic Value_10Y_max---0.007--------
Intrinsic Value_10Y_min---0.016--------
Intrinsic Value_1Y_max---0.024--------
Intrinsic Value_1Y_min---0.024--------
Intrinsic Value_3Y_max---0.055--------
Intrinsic Value_3Y_min---0.053--------
Intrinsic Value_5Y_max---0.064--------
Intrinsic Value_5Y_min---0.061--------
Market Cap11976212.544+2%11766103.55210925667.584+8%45698705.760-74%26383686.281-55%26383686.281-55%
Net Profit Margin---0.297-0.520+75%-977.964+329186%-558.572+187975%-558.572+187975%
Operating Margin---0.235-0.488+108%-983.097+417634%-548.997+233178%-548.997+233178%
Operating Ratio--1.1561.204-4%979.430-100%502.282-100%502.282-100%
Pb Ratio5.662+2%5.5626.003-7%12.862-57%6.623-16%6.623-16%
Pe Ratio-21.583-2%-21.204-12.285-42%-6.853-68%-7.731-64%-7.731-64%
Price Per Share0.057+2%0.0560.052+8%0.218-74%0.126-55%0.126-55%
Price To Free Cash Flow Ratio-4.499-2%-4.421-4.086-8%-6.792+54%-4.530+2%-4.530+2%
Quick Ratio--6.1014.144+47%7.518-19%8.844-31%8.844-31%
Return On Assets---0.058-0.202+250%-0.670+1063%-0.399+593%-0.399+593%
Return On Equity---0.066-0.245+273%-0.785+1097%-0.460+602%-0.460+602%
Total Gains Per Share---0.0000%-0.0070%0.001-100%0.001-100%
Usd Book Value--1414059.3321238281.937+14%2541476.560-44%2458259.197-42%2458259.197-42%
Usd Book Value Change Per Share---0.0000%-0.0050%0.000-100%0.000-100%
Usd Book Value Per Share--0.0070.006+14%0.012-44%0.012-42%0.012-42%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.000-0.001+193%-0.005+1126%-0.003+642%-0.003+642%
Usd Free Cash Flow---444835.944-476656.210+7%-1450220.168+226%-965196.583+117%-965196.583+117%
Usd Free Cash Flow Per Share---0.002-0.002+7%-0.007+226%-0.005+117%-0.005+117%
Usd Free Cash Flow To Equity Per Share---0.001-0.002+114%-0.006+648%-0.001-24%-0.001-24%
Usd Market Cap8006098.086+2%7865640.2257303808.780+8%30549584.801-74%17637494.279-55%17637494.279-55%
Usd Price Per Share0.038+2%0.0370.035+8%0.145-74%0.084-55%0.084-55%
Usd Profit---92736.326-271590.325+193%-1705194.425+1739%-941261.943+915%-941261.943+915%
Usd Revenue--312248.997459644.890-32%2023.048+15335%178117.528+75%178117.528+75%
Usd Total Gains Per Share---0.0000%-0.0050%0.000-100%0.000-100%
 EOD+5 -2MRQTTM+27 -2YOY+20 -95Y+16 -1710Y+16 -17

3.3 Fundamental Score

Let's check the fundamental score of Firebrick Pharma Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-21.583
Price to Book Ratio (EOD)Between0-15.662
Net Profit Margin (MRQ)Greater than0-0.297
Operating Margin (MRQ)Greater than0-0.235
Quick Ratio (MRQ)Greater than16.101
Current Ratio (MRQ)Greater than17.188
Debt to Asset Ratio (MRQ)Less than10.121
Debt to Equity Ratio (MRQ)Less than10.138
Return on Equity (MRQ)Greater than0.15-0.066
Return on Assets (MRQ)Greater than0.05-0.058
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Firebrick Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.029
Ma 20Greater thanMa 500.058
Ma 50Greater thanMa 1000.058
Ma 100Greater thanMa 2000.055
OpenGreater thanClose0.057
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Firebrick Pharma Ltd

Firebrick Pharma Limited engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia. The company offers broad-spectrum antimicrobial nasal spray for the treatment of common cold under the Nasodine name. It also operates in the United states and Singapore. Firebrick Pharma Limited was incorporated in 2012 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-11-01 22:52:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Firebrick Pharma Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -29.7% means that $-0.30 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Firebrick Pharma Ltd:

  • The MRQ is -29.7%. The company is making a huge loss. -2
  • The TTM is -52.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-29.7%TTM-52.0%+22.3%
TTM-52.0%YOY-97,796.4%+97,744.4%
TTM-52.0%5Y-55,857.2%+55,805.2%
5Y-55,857.2%10Y-55,857.2%0.0%
4.3.1.2. Return on Assets

Shows how efficient Firebrick Pharma Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • -5.8% Return on Assets means that Firebrick Pharma Ltd generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Firebrick Pharma Ltd:

  • The MRQ is -5.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.8%TTM-20.2%+14.4%
TTM-20.2%YOY-67.0%+46.8%
TTM-20.2%5Y-39.9%+19.7%
5Y-39.9%10Y-39.9%0.0%
4.3.1.3. Return on Equity

Shows how efficient Firebrick Pharma Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • -6.6% Return on Equity means Firebrick Pharma Ltd generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Firebrick Pharma Ltd:

  • The MRQ is -6.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.6%TTM-24.5%+17.9%
TTM-24.5%YOY-78.5%+54.0%
TTM-24.5%5Y-46.0%+21.6%
5Y-46.0%10Y-46.0%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Firebrick Pharma Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Firebrick Pharma Ltd is operating .

  • Measures how much profit Firebrick Pharma Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of -23.5% means the company generated $-0.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Firebrick Pharma Ltd:

  • The MRQ is -23.5%. The company is operating very inefficient. -2
  • The TTM is -48.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-23.5%TTM-48.8%+25.3%
TTM-48.8%YOY-98,309.7%+98,260.8%
TTM-48.8%5Y-54,899.7%+54,850.9%
5Y-54,899.7%10Y-54,899.7%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Firebrick Pharma Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are $1.16 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 1.156. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.204. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.156TTM1.204-0.048
TTM1.204YOY979.430-978.226
TTM1.2045Y502.282-501.078
5Y502.28210Y502.2820.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Firebrick Pharma Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Firebrick Pharma Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 7.19 means the company has $7.19 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 7.188. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.177. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.188TTM6.177+1.011
TTM6.177YOY7.808-1.631
TTM6.1775Y9.761-3.584
5Y9.76110Y9.7610.000
4.4.3.2. Quick Ratio

Measures if Firebrick Pharma Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 6.10 means the company can pay off $6.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 6.101. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.144. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.101TTM4.144+1.957
TTM4.144YOY7.518-3.374
TTM4.1445Y8.844-4.700
5Y8.84410Y8.8440.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Firebrick Pharma Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Firebrick Pharma Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Firebrick Pharma Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.12 means that Firebrick Pharma Ltd assets are financed with 12.1% credit (debt) and the remaining percentage (100% - 12.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 0.121. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.152. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.121TTM0.152-0.031
TTM0.152YOY0.129+0.023
TTM0.1525Y0.114+0.038
5Y0.11410Y0.1140.000
4.5.4.2. Debt to Equity Ratio

Measures if Firebrick Pharma Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 13.8% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 0.138. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.181. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.181-0.043
TTM0.181YOY0.151+0.030
TTM0.1815Y0.132+0.048
5Y0.13210Y0.1320.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Firebrick Pharma Ltd generates.

  • Above 15 is considered overpriced but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of -21.20 means the investor is paying $-21.20 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Firebrick Pharma Ltd:

  • The EOD is -21.583. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.204. Based on the earnings, the company is expensive. -2
  • The TTM is -12.285. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.583MRQ-21.204-0.379
MRQ-21.204TTM-12.285-8.919
TTM-12.285YOY-6.853-5.432
TTM-12.2855Y-7.731-4.555
5Y-7.73110Y-7.7310.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Firebrick Pharma Ltd:

  • The EOD is -4.499. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.421. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.086. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.499MRQ-4.421-0.079
MRQ-4.421TTM-4.086-0.335
TTM-4.086YOY-6.792+2.706
TTM-4.0865Y-4.530+0.444
5Y-4.53010Y-4.5300.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Firebrick Pharma Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 5.56 means the investor is paying $5.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Firebrick Pharma Ltd:

  • The EOD is 5.662. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.562. Based on the equity, the company is overpriced. -1
  • The TTM is 6.003. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.662MRQ5.562+0.099
MRQ5.562TTM6.003-0.441
TTM6.003YOY12.862-6.859
TTM6.0035Y6.623-0.619
5Y6.62310Y6.6230.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets2,406
Total Liabilities291
Total Stockholder Equity2,115
 As reported
Total Liabilities 291
Total Stockholder Equity+ 2,115
Total Assets = 2,406

Assets

Total Assets2,406
Total Current Assets2,092
Long-term Assets314
Total Current Assets
Cash And Cash Equivalents 825
Net Receivables 951
Inventory 240
Other Current Assets 77
Total Current Assets  (as reported)2,092
Total Current Assets  (calculated)2,092
+/-0
Long-term Assets
Property Plant Equipment 27
Long-term Assets Other 287
Long-term Assets  (as reported)314
Long-term Assets  (calculated)314
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities291
Long-term Liabilities0
Total Stockholder Equity2,115
Total Current Liabilities
Accounts payable 69
Other Current Liabilities 222
Total Current Liabilities  (as reported)291
Total Current Liabilities  (calculated)291
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock17,883
Retained Earnings -16,512
Accumulated Other Comprehensive Income 744
Total Stockholder Equity (as reported)2,115
Total Stockholder Equity (calculated)2,115
+/-0
Other
Cash and Short Term Investments 825
Common Stock Shares Outstanding 181,666
Liabilities and Stockholders Equity 2,406
Net Debt -825
Net Working Capital 1,801



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
0
1,761
1,761
4,930
4,930
8,729
8,729
5,625
5,625
2,982
2,982
1,945
1,945
2,406
2,406
2,4062,4061,9451,9452,9822,9825,6255,6258,7298,7294,9304,9301,7611,76100
   > Total Current Assets 
93
0
1,669
1,669
4,538
4,538
8,328
8,328
5,227
5,227
2,589
2,589
1,839
1,839
2,092
2,092
2,0922,0921,8391,8392,5892,5895,2275,2278,3288,3284,5384,5381,6691,669093
       Cash And Cash Equivalents 
-93
0
1,152
1,152
4,316
4,316
7,143
7,143
4,909
4,909
2,355
2,355
1,305
1,305
825
825
8258251,3051,3052,3552,3554,9094,9097,1437,1434,3164,3161,1521,1520-93
       Short-term Investments 
185
0
11
11
6
6
0
0
5
5
0
0
5
5
0
0
00550055006611110185
       Net Receivables 
0
0
0
503
90
90
1,082
1,082
118
118
137
137
0
93
1
951
95119301371371181181,0821,0829090503000
       Other Current Assets 
0
0
506
14
216
132
1,185
104
313
200
235
97
245
157
1,027
77
771,027157245972352003131041,1851322161450600
   > Long-term Assets 
-93
0
92
92
391
391
401
401
398
398
393
393
106
106
314
314
31431410610639339339839840140139139192920-93
       Property Plant Equipment 
0
0
16
16
32
32
42
42
39
39
34
34
30
30
27
27
272730303434393942423232161600
       Long-term Assets Other 
-93
0
76
76
359
359
359
359
359
359
359
359
76
76
287
287
287287767635935935935935935935935976760-93
> Total Liabilities 
0
0
215
215
322
322
450
450
498
498
506
506
356
356
291
291
29129135635650650649849845045032232221521500
   > Total Current Liabilities 
0
0
215
215
322
322
450
450
498
498
506
506
356
356
291
291
29129135635650650649849845045032232221521500
       Short-term Debt 
0
0
0
0
94
94
0
0
0
0
0
0
0
0
0
0
000000000094940000
       Accounts payable 
0
0
35
35
28
28
36
36
209
209
197
197
90
90
69
69
6969909019719720920936362828353500
       Other Current Liabilities 
0
0
180
180
199
199
414
414
289
289
309
309
266
266
222
222
22222226626630930928928941441419919918018000
   > Long-term Liabilities 0000000000000000
> Total Stockholder Equity
391
0
1,546
1,546
4,607
4,607
8,279
8,279
5,128
5,128
2,476
2,476
1,589
1,589
2,115
2,115
2,1152,1151,5891,5892,4762,4765,1285,1288,2798,2794,6074,6071,5461,5460391
   Common Stock
0
0
5,774
5,774
10,194
10,194
16,000
16,000
16,002
16,002
17,068
17,068
17,080
17,080
17,883
17,883
17,88317,88317,08017,08017,06817,06816,00216,00216,00016,00010,19410,1945,7745,77400
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 
391
0
806
806
964
964
1,085
1,085
1,033
1,033
987
987
844
844
744
744
7447448448449879871,0331,0331,0851,0859649648068060391
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
964
1,085
1,085
1,033
0
987
987
0
0
0
0
000098798701,0331,0851,08596400000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue15
Cost of Revenue-37
Gross Profit-23-23
 
Operating Income (+$)
Gross Profit-23
Operating Expense-3,905
Operating Income-3,928-3,928
 
Operating Expense (+$)
Research Development1,905
Selling General Administrative218
Selling And Marketing Expenses256
Operating Expense3,9052,379
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1
Other Finance Cost-1
Net Interest Income0
 
Pretax Income (+$)
Operating Income-3,928
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,176-6,679
EBIT - interestExpense = -1,176
-3,912
-1,175
Interest Expense1
Earnings Before Interest and Taxes (EBIT)-1,175-1,175
Earnings Before Interest and Taxes (EBITDA)-1,168
 
After tax Income (+$)
Income Before Tax-1,176
Tax Provision-0
Net Income From Continuing Ops0-1,176
Net Income-1,176
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,694
Total Other Income/Expenses Net2,7520
 

Technical Analysis of Firebrick Pharma Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Firebrick Pharma Ltd. The general trend of Firebrick Pharma Ltd is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Firebrick Pharma Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Firebrick Pharma Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.06 < 0.06 < 0.06.

The bearish price targets are: 0.056 > 0.055 > 0.055.

Tweet this
Firebrick Pharma Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Firebrick Pharma Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Firebrick Pharma Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Firebrick Pharma Ltd. The current macd is -0.00024916.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Firebrick Pharma Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Firebrick Pharma Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Firebrick Pharma Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Firebrick Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) ChartFirebrick Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Firebrick Pharma Ltd. The current adx is 15.68.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Firebrick Pharma Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Firebrick Pharma Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Firebrick Pharma Ltd. The current sar is 0.0599.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Firebrick Pharma Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Firebrick Pharma Ltd. The current rsi is 49.03. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Firebrick Pharma Ltd Daily Relative Strength Index (RSI) ChartFirebrick Pharma Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Firebrick Pharma Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Firebrick Pharma Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Firebrick Pharma Ltd Daily Stochastic Oscillator ChartFirebrick Pharma Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Firebrick Pharma Ltd. The current cci is -30.34752814.

Firebrick Pharma Ltd Daily Commodity Channel Index (CCI) ChartFirebrick Pharma Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Firebrick Pharma Ltd. The current cmo is -2.37487301.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Firebrick Pharma Ltd Daily Chande Momentum Oscillator (CMO) ChartFirebrick Pharma Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Firebrick Pharma Ltd. The current willr is -60.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Firebrick Pharma Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Firebrick Pharma Ltd Daily Williams %R ChartFirebrick Pharma Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Firebrick Pharma Ltd. The current atr is 0.00193611.

Firebrick Pharma Ltd Daily Average True Range (ATR) ChartFirebrick Pharma Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Firebrick Pharma Ltd. The current obv is -709,340.

Firebrick Pharma Ltd Daily On-Balance Volume (OBV) ChartFirebrick Pharma Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Firebrick Pharma Ltd. The current mfi is 85.46.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Firebrick Pharma Ltd Daily Money Flow Index (MFI) ChartFirebrick Pharma Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Firebrick Pharma Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Firebrick Pharma Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Firebrick Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.029
Ma 20Greater thanMa 500.058
Ma 50Greater thanMa 1000.058
Ma 100Greater thanMa 2000.055
OpenGreater thanClose0.057
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Firebrick Pharma Ltd with someone you think should read this too:
  • Are you bullish or bearish on Firebrick Pharma Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Firebrick Pharma Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Firebrick Pharma Ltd

I send you an email if I find something interesting about Firebrick Pharma Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Firebrick Pharma Ltd.

Receive notifications about Firebrick Pharma Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.